Nippon Life Global Investors Americas’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-142,890
| Closed | -$10.4M | – | 152 |
|
|
2021
Q4 | $10.4M | Buy |
142,890
+11,610
| +9% | +$800K | 0.49% | 57 |
|
|
2021
Q3 | $9.17M | Sell |
131,280
-19,230
| -13% | -$1.35M | 0.48% | 59 |
|
|
2021
Q2 | $10.4M | Sell |
150,510
-8,480
| -5% | -$566K | 0.52% | 57 |
|
|
2021
Q1 | $10.3M | Buy |
158,990
+2,840
| +2% | +$183K | 0.56% | 53 |
|
|
2020
Q4 | $9.1M | Hold |
156,150
| – | – | 0.54% | 54 |
|
|
2020
Q3 | $9.87M | Buy |
156,150
+13,920
| +10% | +$965K | 0.65% | 45 |
|
|
2020
Q2 | $10.9M | Buy |
142,230
+107,940
| +315% | +$8.27M | 0.78% | 34 |
|
|
2020
Q1 | $2.56M | Sell |
34,290
-71,686
| -68% | -$4.95M | 0.22% | 92 |
|
|
2019
Q4 | $6.89M | Buy |
105,976
+13,180
| +14% | +$858K | 0.47% | 65 |
|
|
2019
Q3 | $5.88M | Hold |
92,796
| – | – | 0.43% | 72 |
|
|
2019
Q2 | $6.27M | Buy |
92,796
+4,000
| +5% | +$263K | 0.48% | 63 |
|
|
2019
Q1 | $5.77M | Sell |
88,796
-4,150
| -4% | -$276K | 0.46% | 71 |
|
|
2018
Q4 | $5.81M | Sell |
92,946
-116,530
| -56% | -$8.14M | 0.5% | 62 |
|
|
2018
Q3 | $16.2M | Sell |
209,476
-40,840
| -16% | -$3.08M | 1.23% | 26 |
|
|
2018
Q2 | $17.7M | Sell |
250,316
-41,230
| -14% | -$2.91M | 1.41% | 20 |
|
|
2018
Q1 | $22M | Sell |
291,546
-27,580
| -9% | -$2.19M | 1.81% | 9 |
|
|
2017
Q4 | $22.9M | Buy |
319,126
+29,310
| +10% | +$2.23M | 1.82% | 11 |
|
|
2017
Q3 | $23.5M | Buy |
289,816
+4,910
| +2% | +$375K | 2% | 9 |
|
|
2017
Q2 | $20.2M | Hold |
284,906
| – | – | 1.73% | 11 |
|
|
2017
Q1 | $19.4M | Buy |
284,906
+68,220
| +31% | +$4.8M | 1.72% | 10 |
|
|
2016
Q4 | $15.5M | Buy |
216,686
+7,960
| +4% | +$592K | 1.43% | 17 |
|
|
2016
Q3 | $16.5M | Hold |
208,726
| – | – | 1.56% | 15 |
|
|
2016
Q2 | $17.4M | Sell |
208,726
-14,580
| -7% | -$1.29M | 1.66% | 13 |
|
|
2016
Q1 | $20.5M | Sell |
223,306
-5,010
| -2% | -$452K | 1.95% | 7 |
|
|
2015
Q4 | $23.1M | Hold |
228,316
| – | – | 2.17% | 5 |
|
|
2015
Q3 | $22.4M | Buy |
228,316
+35,810
| +19% | +$3.98M | 2.25% | 4 |
|
|
2015
Q2 | $22.5M | Buy |
192,506
+7,720
| +4% | +$844K | 2.03% | 4 |
|
|
2015
Q1 | $18.1M | Buy |
184,786
+83,070
| +82% | +$8.44M | 1.66% | 11 |
|
|
2014
Q4 | $9.59M | Buy |
101,716
+35,390
| +53% | +$3.66M | 0.88% | 43 |
|
|
2014
Q3 | $7.06M | Sell |
66,326
-29,440
| -31% | -$2.88M | 0.67% | 58 |
|
|
2014
Q2 | $7.94M | Buy |
95,766
+29,440
| +44% | +$2.29M | 0.75% | 54 |
|
|
2014
Q1 | $4.7M | Sell |
66,326
-9,370
| -12% | -$735K | 0.46% | 81 |
|
|
2013
Q4 | $5.69M | Sell |
75,696
-45,270
| -37% | -$3.15M | 0.56% | 78 |
|
|
2013
Q3 | $7.6M | Sell |
120,966
-23,160
| -16% | -$1.38M | 0.82% | 53 |
|
|
2013
Q2 | $7.38M | Buy |
+144,126
| New | +$7.51M | 0.82% | 51 |
|
Other funds holding GILD
Nippon Life Global Investors Americas's GILD Position: Q1 2022 in Review
Nippon Life Global Investors Americas sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 142,890 shares — an estimated $10.4M sold.
Nippon Life Global Investors Americas first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $23.5M in Q3 2017. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Nippon Life Global Investors Americas reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Nippon Life Global Investors Americas sold 142,890 Gilead Sciences shares in Q1 2022, an estimated $10.4M.
- Nippon Life Global Investors Americas first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Nippon Life Global Investors Americas's Gilead Sciences position peaked at $23.5M in Q3 2017.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Nippon Life Global Investors Americas's 13F filing for Q1 2022, filed 11 May 2022.